Cargando…

Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients

BACKGROUND: CBX7 is a Polycomb group protein that shows variable expression changes in various cancers that are often contradictive. A mouse knockout experiment has validated the tumor suppressor role in carcinogenesis. The purpose of this study is to verify the tumor suppressor role of Cbx7 in huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiang, Zhou, Jing, Zhang, Baozhen, Zhang, Jun, Wilson, James, Gu, Liankun, Zhu, Budong, Gu, Jin, Ji, Jiafu, Deng, Dajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365772/
https://www.ncbi.nlm.nih.gov/pubmed/25881303
http://dx.doi.org/10.1186/s12885-015-1172-6
_version_ 1782362281255895040
author Zheng, Xiang
Zhou, Jing
Zhang, Baozhen
Zhang, Jun
Wilson, James
Gu, Liankun
Zhu, Budong
Gu, Jin
Ji, Jiafu
Deng, Dajun
author_facet Zheng, Xiang
Zhou, Jing
Zhang, Baozhen
Zhang, Jun
Wilson, James
Gu, Liankun
Zhu, Budong
Gu, Jin
Ji, Jiafu
Deng, Dajun
author_sort Zheng, Xiang
collection PubMed
description BACKGROUND: CBX7 is a Polycomb group protein that shows variable expression changes in various cancers that are often contradictive. A mouse knockout experiment has validated the tumor suppressor role in carcinogenesis. The purpose of this study is to verify the tumor suppressor role of Cbx7 in human colon carcinomas (CC). METHODS: Frozen CC and the surgical margin (SM) tissue samples from patients (n = 97) were obtained from the Peking University Cancer Hospital. All patients had follow-up data for at least three years. The level of Cbx7 mRNA and protein was determined by quantitative RT-PCR, immunohistochemistry and Western blot, respectively. The association between Cbx7 mRNA level and clinicopathological characteristics of CC patients was then statistically analyzed. RESULTS: CBX7 expression changes detected through immunohistochemistry and Western blot in 10 pairs of representative CC samples significantly correlated with their corresponding mRNA levels when Alu, but not GAPDH, was used as the endogenous reference control in quantitative RT-PCR. The Alu-normalized Cbx7 mRNA levels were significantly increased in SM tissues when compared with CC tissues or colon biopsies taken from non-cancer patients (Student’s t-test, P < 0.036 or 0.007). Furthermore, decreased levels of Cbx7 mRNA positively correlated with lymph metastasis (P = 0.029). Overall survival (OS) of CC patients classified as Cbx7 expression-low was considerably shorter than those classified as Cbx7 expression-high (Hazard ratio = 2.97, 95% CI [1.68 ~ 5.25]; P <0.001). Multiple variant analyses showed that the Cbx7 expression-low was an independent predictor of short OS (Hazard ratio = 3.16, 95% CI [1.58-6.30]; P < 0.001). CONCLUSION: Cbx7 is downregulated in CCs, and Cbx7 expression-low tumors correlated with lymph metastasis and poor overall survival of CC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1172-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4365772
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43657722015-03-20 Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients Zheng, Xiang Zhou, Jing Zhang, Baozhen Zhang, Jun Wilson, James Gu, Liankun Zhu, Budong Gu, Jin Ji, Jiafu Deng, Dajun BMC Cancer Research Article BACKGROUND: CBX7 is a Polycomb group protein that shows variable expression changes in various cancers that are often contradictive. A mouse knockout experiment has validated the tumor suppressor role in carcinogenesis. The purpose of this study is to verify the tumor suppressor role of Cbx7 in human colon carcinomas (CC). METHODS: Frozen CC and the surgical margin (SM) tissue samples from patients (n = 97) were obtained from the Peking University Cancer Hospital. All patients had follow-up data for at least three years. The level of Cbx7 mRNA and protein was determined by quantitative RT-PCR, immunohistochemistry and Western blot, respectively. The association between Cbx7 mRNA level and clinicopathological characteristics of CC patients was then statistically analyzed. RESULTS: CBX7 expression changes detected through immunohistochemistry and Western blot in 10 pairs of representative CC samples significantly correlated with their corresponding mRNA levels when Alu, but not GAPDH, was used as the endogenous reference control in quantitative RT-PCR. The Alu-normalized Cbx7 mRNA levels were significantly increased in SM tissues when compared with CC tissues or colon biopsies taken from non-cancer patients (Student’s t-test, P < 0.036 or 0.007). Furthermore, decreased levels of Cbx7 mRNA positively correlated with lymph metastasis (P = 0.029). Overall survival (OS) of CC patients classified as Cbx7 expression-low was considerably shorter than those classified as Cbx7 expression-high (Hazard ratio = 2.97, 95% CI [1.68 ~ 5.25]; P <0.001). Multiple variant analyses showed that the Cbx7 expression-low was an independent predictor of short OS (Hazard ratio = 3.16, 95% CI [1.58-6.30]; P < 0.001). CONCLUSION: Cbx7 is downregulated in CCs, and Cbx7 expression-low tumors correlated with lymph metastasis and poor overall survival of CC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1172-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-18 /pmc/articles/PMC4365772/ /pubmed/25881303 http://dx.doi.org/10.1186/s12885-015-1172-6 Text en © Zheng et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zheng, Xiang
Zhou, Jing
Zhang, Baozhen
Zhang, Jun
Wilson, James
Gu, Liankun
Zhu, Budong
Gu, Jin
Ji, Jiafu
Deng, Dajun
Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients
title Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients
title_full Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients
title_fullStr Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients
title_full_unstemmed Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients
title_short Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients
title_sort critical evaluation of cbx7 downregulation in primary colon carcinomas and its clinical significance in chinese patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365772/
https://www.ncbi.nlm.nih.gov/pubmed/25881303
http://dx.doi.org/10.1186/s12885-015-1172-6
work_keys_str_mv AT zhengxiang criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients
AT zhoujing criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients
AT zhangbaozhen criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients
AT zhangjun criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients
AT wilsonjames criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients
AT guliankun criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients
AT zhubudong criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients
AT gujin criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients
AT jijiafu criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients
AT dengdajun criticalevaluationofcbx7downregulationinprimarycoloncarcinomasanditsclinicalsignificanceinchinesepatients